Divgi CR - Search Results

1

Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.

Pianko MJ, Terpos E, Roodman GD, Divgi CR, Zweegman S, Hillengass J, Lentzsch S. Pianko MJ, et al. Among authors: divgi cr. Clin Cancer Res. 2014 Dec 1;20(23):5888-97. doi: 10.1158/1078-0432.CCR-14-1692. Epub 2014 Oct 7. Clin Cancer Res. 2014. PMID: 25294899 Review.

2

Imaging approaches with advanced prostate cancer: techniques and timing.

Leung D, Krishnamoorthy S, Schwartz L, Divgi C. Leung D, et al. Can J Urol. 2014 Apr;21(2 Supp 1):42-7. Can J Urol. 2014. PMID: 24775723 Free article. Review.

3

Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.

Divgi CR, Uzzo RG, Gatsonis C, Bartz R, Treutner S, Yu JQ, Chen D, Carrasquillo JA, Larson S, Bevan P, Russo P. Divgi CR, et al. J Clin Oncol. 2013 Jan 10;31(2):187-94. doi: 10.1200/JCO.2011.41.2445. Epub 2012 Dec 3. J Clin Oncol. 2013. PMID: 23213092 Free PMC article. Clinical Trial.

4

Optimizing prostate cancer treatment by combining local radiation therapy with systemic vaccination.

Kaufman HL, Divgi CR. Kaufman HL, et al. Among authors: divgi cr. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6757-62. doi: 10.1158/1078-0432.CCR-05-0644. Clin Cancer Res. 2005. PMID: 16203760 Review. No abstract available.

5

Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.

Slovin SF, Scher HI, Divgi CR, Reuter V, Sgouros G, Moore M, Weingard K, Pettengall R, Imbriaco M, El-Shirbiny A, Finn R, Bronstein J, Brett C, Milenic D, Dnistrian A, Shapiro L, Schlom J, Larson SM. Slovin SF, et al. Among authors: divgi cr. Clin Cancer Res. 1998 Mar;4(3):643-51. Clin Cancer Res. 1998. PMID: 9533532

6

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.

Divgi CR, Bander NH, Scott AM, O'Donoghue JA, Sgouros G, Welt S, Finn RD, Morrissey F, Capitelli P, Williams JM, Deland D, Nakhre A, Oosterwijk E, Gulec S, Graham MC, Larson SM, Old LJ. Divgi CR, et al. Clin Cancer Res. 1998 Nov;4(11):2729-39. Clin Cancer Res. 1998. PMID: 9829736 Clinical Trial.

7

Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.

Rosenblat TL, McDevitt MR, Mulford DA, Pandit-Taskar N, Divgi CR, Panageas KS, Heaney ML, Chanel S, Morgenstern A, Sgouros G, Larson SM, Scheinberg DA, Jurcic JG. Rosenblat TL, et al. Among authors: divgi cr. Clin Cancer Res. 2010 Nov 1;16(21):5303-11. doi: 10.1158/1078-0432.CCR-10-0382. Epub 2010 Sep 21. Clin Cancer Res. 2010. PMID: 20858843 Free PMC article. Clinical Trial.

8

Gallium-67-citrate imaging in nuclear oncology.

Macapinlac HA, Scott AM, Larson SM, Divgi CR, Yeh SD, Goldsmith SJ. Macapinlac HA, et al. Among authors: divgi cr. Nucl Med Biol. 1994 Jul;21(5):731-8. doi: 10.1016/0969-8051(94)90044-2. Nucl Med Biol. 1994. PMID: 9241649

9

Pulmonary applications of nuclear medicine.

Kramer EL, Divgi CR. Kramer EL, et al. Among authors: divgi cr. Clin Chest Med. 1991 Mar;12(1):55-75. Clin Chest Med. 1991. PMID: 2009745 Review.

10

A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III).

Crawford ED, Koo PJ, Shore N, Slovin SF, Concepcion RS, Freedland SJ, Gomella LG, Karsh L, Keane TE, Maroni P, Penson D, Petrylak DP, Ross A, Mouraviev V, Reiter RE, Divgi C, Yu EY; RADAR III Group. Crawford ED, et al. J Urol. 2019 Apr;201(4):682-692. doi: 10.1016/j.juro.2018.05.164. J Urol. 2019. PMID: 30077557 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters